Question · asked by 1 review
Summary of findings ‐ weekly azithromycin vs daily azithromycin: FEV1 (% predicted): mean change from baseline
- Population
- adults and children with cystic fibrosis
- Intervention
- Summary of findings ‐ weekly azithromycin
- Comparison
- daily azithromycin
- Outcome
- FEV1 (% predicted): mean change from baseline
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Summary of findings ‐ weekly azithromycin vs daily azithromycin FEV1 % predicted: mean change % predicted · adults and children with cystic fibrosis Macrolide antibiotics (including azithromycin) for cystic fibrosis (2024) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 208 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Macrolide antibiotics (including azithromycin) for cystic fibrosis 2024 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.